AXSM EPS Estimates
Axsome Therapeutics, Inc.
$161.79
-$0.43(-0.27%)
40
Overall
40
Value
9
Tech
71
Quality
Market Cap
$8.50B
Volume
802.58K
52W Range
$119.20 - $260.19
Target Price
$279.55
AXSM EPS estimates: the consensus estimate for Axsome Therapeutics, Inc.'s current fiscal year is -$2.92 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AXSM EPS Estimates
- EPS estimate, current quarter
- $-0.59
- EPS estimate, next quarter
- $-0.05
- EPS estimate, current year
- $-2.92
- EPS estimate, next year
- $3.78
- EPS growth, 3-year
- +7.17%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.68 |
| 2024 | $-5.99 |
| 2023 | $-5.27 |
| 2022 | $-4.60 |
| 2021 | $-3.47 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXSM | $161.79 | -0.3% | 802.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Axsome Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW